ByteDance Just Made a $1.5B AI Drug Bet—Could This Change Medicine Forever? Here’s Why
Anew Labs raised $290 million at a $1.5 billion valuation. Explore ByteDance’s stake and the gap between AI research and approved medicines.
Anew Labs raised $290 million at a $1.5 billion valuation. Explore ByteDance’s stake and the gap between AI research and approved medicines.
Security experts propose AI incident hotlines and human control to reduce the risk of unintended escalation between the US and China.
MediaTek’s Dimensity 9600 Pro points toward larger AI models on phones. Explore performance, power, privacy, and cloud trade-offs.
Salesforce and Nvidia’s Koa targets enterprise reasoning with open weights. Explore cost, control, and the questions behind the claims.
AI leaders’ calls for restraint meet resistance to government-led pacing. Explore the safety debate and competitive pressures.
Barack Obama calls for AI safeguards as private development accelerates. Explore the debate over oversight, jobs, innovation, and security.
Anthropic reports misuse involving military, surveillance, and biological research contexts. Explore the findings and oversight questions.
Lawmakers consider stronger AI safeguards after warnings about advanced systems. Explore proposed pauses, intervention tools, and political hurdles.
Explore reported AI misuse in biological research and the debate over evaluations, verification, oversight, and responsible access.
Meta’s Stilla AI acquisition points toward more capable business agents across messaging platforms. Explore customer-service implications.